POLYMER -LIPID HYBRID NANOPARTICLES FOR BRAIN TARGETING THROUGH INTRANASAL DELIVERY

Rajeshwar Kamal Kant Arya, Vijay Juyal

Abstract


Brain targeting is a difficult task due to various factors; those factors can restrict the entry of drugs into the brain, in the present study polymer-lipid hybrid nanoparticles were prepared for targeting carbamazepine into the brain through the intranasal route. Five formulations were successfully prepared using chitosan, stearic acid and glyceryl mono stearate in different ratio. The particles size were found between 78.88-790nm, the poly dispersibility index were found in the range of 0.273-0.531, the zeta potential were found to be -7.1, -11.6, 22.3 for HN1, HN2, HN3 respectively and for formulation HN4 and HN5 it was found as +12.1 and +22.3. The entrapment efficiency of all the formulations was found between 62.66-88.31%, the in-vitro releases were found in the range of 40-72%. The in-vivo studies were performed on Wister rats. Formulation HN5 containing higher conc. of chitosan has shown high drug targeting efficiency. The lipid-polymer hybrid nanoparticles have shown the possibility of targeting the brain through intranasal delivery.

Keywords: polymer-lipid hybrid Nanoparticles, carbamazepine, brain targeting, chitosan

 


References


Arya RKK, Juyal V, Kunwar N, Preparation of carbamazepine chitosan nanoparticles for improving nasal absorption, Journal of Drug Delivery and Therapeutics, 2015; 5(3):101-108. DOI: 10.22270/jddt.v5i3.1090

Serralheiro A, Gilberto A, Ana F, Amílcar F, Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting, Euro. J. of Pharma Sci, 2014, doi:dx. Doi.org/10. 1016/j.ejps. 2014. 04.019.

Gavini E, Hegge A B, Rassu G, Sanna V, Testa C, Pirisino G, Karlsen J, Giunchedi P Nasal administration of carbamazepine using chitosan microspheres: In-vitro/in-vivo studies, Int. J. Pharm, 2006; 307:9-15.

Barakat NS, Omar SA, Ahmed AAE, Carbamazepine uptake into rat brain following intra-olfactory transport, J. of Pharmacology, 2006; 58:63–72

Lee VH, Robinson JR, Controlled drug delivery fundamental and application 2nd ed. revised and expanded. Dekker. New York; 2005. P. 29, 4.

Ni S, Nanoparticles carrying natural product for drug delivery, Journal of Drug Delivery and Therapeutics. 2017; 7(3):73-75 DOI: http://dx.doi.org/10.22270/jddt.v7i3.1425

Ravi MNV, Handbook of Particulate drug delivery, American Sci publishers, California, vol 2, 96-161.

Mygind N, Dahl R, Anatomy and physiology of the nasal cavities in health and disease, adv. drug del. Rev, 1998; 29:3-12.

Chein YW, Novel drug delivery systems, 2nd ed. New York, Marcel Dekker Inc; 1993. P. 269-300.

Yildiz O, Particulate carrier for nasal administration, handbook of particulate drug delivery, American scientific publisher, 2008. P. 143-161.

Sharma PK, Garg G, Salim M, Review on nasal drug delivery system with recent advancemnt, Int. J. Pharm. and Pharma. Sci., 2011; 3:6-11.

Nanosponges–a boon to the targeted drug delivery system, Yadav GV, Panchory HP, Journal of drug delivery and therapeutics, 2013; 3(4):151-155

Jadhav KR, Manoj N, Gambhire, Shaikh IM, Nasal drug delivery system-factors affecting and applications, Cur. Drug Therapy, 2007; 2:27-38.

Wong H, Rauth AM, Bendayan R, Wu XY, In-Vivo evaluation of a new polymer-lipid hybrid nanoparticles (Pln) formulation of doxorubicin in a murine solid tumor model. Eur. J. Pharma. Biopharma., 2007; 65:300–308.

Jian L, Li W, Shen YZ, Li YR, Wang YF, A novel polymer lipid nanoparticle for efficient nonviral gene delivery, Acta Pharm. Sinca, 2010; 31:509-514.

Wang J, Ballanco CO, Xu J, Yang W, Yu X, Preparation and characterization of vinculin-targeted polymer–lipid nanoparticle as intracellular delivery vehicle, Int. J. Nanomed., 2013; 3(8):39-46.

Sailor MJ, Park JH, Hybrid nanoparticles for detection and treatment of cancer, Adv. Mater., 2012; 24(28):3779-3802.

Hadinoto K, Sudaresan A, Cheow WS, Lipid-polymer hybrid nanoparticles as new generation therapeutic delivery platform: A review, Eur. J. of Pharma. Sci., 2013; 85(3):427–443.

Gao J, Xia Y, Chen H, Yu Y, Song J, Li W, Qian W, Wang H Dai J, Guo Y, Polymer-lipid hybrid nanoparticles conjugate with anti-egf receptor antibody for target drug delivery to hepatocellular carcinoma, Nanomedicine 2014; 9(2):279-293

Pal SL, Jana U, Manna PK, Mohanta GP, Manavalan R, Nanoparticles: An overview of preparation and characterization, J. appl. Pharm. Sci. 2011; 1(6):228-234.

Vyas S P, Khar R K, Targeted And Controlled Drug Delivery: Novel Carrier System, Vallabh Prakashan, Delhi,2010 reprint

Lokhandwala H, Deshpande A, Deshpande S, Kinetic modeling and dissolution profiles comparison: an overview, Int. J. Pharm. Bio. Sci., 2013; 4(1):728 –73

Dash S, Murthy P N, Nath L, Chowdhury P, Kinetic modeling on drug release from controlled, Drug delivery systems, Acta Polo. Pharm. Drug Rese, 2010, 67(3)217-223.

Kapoor , Patel M, Vyas RB, Lad C, Lal B, Site specific drug delivery through nasal route using bioadhesive polymers,Journal of Drug Delivery and Therapeutics. 2015; 5(1):1-9

Bagger M, Bechgaard E, A microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug. Int. J. Pharm, 2004, 269, 311-322.

Tripathi D, Arya RKK, Pant M, Nanoparticles: A novel avenue in cancer, Int. J. Pharm. Sci. Rev. Res, 2016; 36(2):90-98.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

footer_848
ISSN: 2250-1177  This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.